Americafirst Capital Management LLC Purchases New Stake in Agilent Technologies, Inc. (A)

Americafirst Capital Management LLC purchased a new position in shares of Agilent Technologies, Inc. (NYSE:A) during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 11,580 shares of the medical research company’s stock, valued at approximately $743,000. Agilent Technologies makes up about 1.0% of Americafirst Capital Management LLC’s investment portfolio, making the stock its 16th biggest holding.

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. BlackRock Inc. lifted its position in Agilent Technologies by 1.2% in the 2nd quarter. BlackRock Inc. now owns 23,392,338 shares of the medical research company’s stock valued at $1,387,400,000 after acquiring an additional 273,119 shares in the last quarter. Vanguard Group Inc. lifted its position in Agilent Technologies by 3.0% in the 2nd quarter. Vanguard Group Inc. now owns 22,093,669 shares of the medical research company’s stock valued at $1,310,374,000 after acquiring an additional 637,698 shares in the last quarter. JPMorgan Chase & Co. lifted its position in Agilent Technologies by 45.2% in the 2nd quarter. JPMorgan Chase & Co. now owns 12,145,610 shares of the medical research company’s stock valued at $720,358,000 after acquiring an additional 3,779,099 shares in the last quarter. Bank of New York Mellon Corp lifted its position in Agilent Technologies by 1.5% in the 2nd quarter. Bank of New York Mellon Corp now owns 5,721,557 shares of the medical research company’s stock valued at $339,346,000 after acquiring an additional 84,801 shares in the last quarter. Finally, American Century Companies Inc. lifted its position in Agilent Technologies by 5.5% in the 2nd quarter. American Century Companies Inc. now owns 4,582,086 shares of the medical research company’s stock valued at $271,764,000 after acquiring an additional 238,522 shares in the last quarter.

Several equities research analysts recently commented on the stock. Morgan Stanley reaffirmed an “overweight” rating on shares of Agilent Technologies in a research report on Tuesday, November 14th. Deutsche Bank set a $68.00 price objective on shares of Agilent Technologies and gave the company a “buy” rating in a research report on Wednesday, August 16th. Bank of America boosted their price objective on shares of Agilent Technologies from $66.00 to $68.00 and gave the company an “equal weight” rating in a research report on Wednesday, August 16th. J P Morgan Chase & Co reaffirmed an “overweight” rating and issued a $70.00 price objective on shares of Agilent Technologies in a research report on Wednesday, August 16th. Finally, Goldman Sachs Group reaffirmed a “neutral” rating and issued a $68.00 price objective on shares of Agilent Technologies in a research report on Tuesday, September 26th. Six analysts have rated the stock with a hold rating and ten have assigned a buy rating to the stock. Agilent Technologies presently has a consensus rating of “Buy” and a consensus target price of $68.34.

In other news, VP Mark Doak sold 4,154 shares of the business’s stock in a transaction dated Tuesday, December 5th. The shares were sold at an average price of $67.00, for a total transaction of $278,318.00. Following the transaction, the vice president now directly owns 68,270 shares in the company, valued at approximately $4,574,090. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Patrick Kaltenbach sold 5,000 shares of the business’s stock in a transaction dated Tuesday, November 28th. The stock was sold at an average price of $69.56, for a total transaction of $347,800.00. Following the transaction, the insider now owns 75,504 shares in the company, valued at $5,252,058.24. The disclosure for this sale can be found here. Insiders have sold a total of 132,576 shares of company stock worth $9,154,784 over the last 90 days.

Shares of Agilent Technologies, Inc. (NYSE A) opened at $66.68 on Thursday. The company has a debt-to-equity ratio of 0.37, a quick ratio of 2.85 and a current ratio of 3.30. Agilent Technologies, Inc. has a 52-week low of $45.36 and a 52-week high of $70.93. The company has a market cap of $21,581.79, a PE ratio of 28.30, a price-to-earnings-growth ratio of 2.03 and a beta of 1.27.

Agilent Technologies (NYSE:A) last issued its quarterly earnings results on Monday, November 20th. The medical research company reported $0.67 EPS for the quarter, topping the consensus estimate of $0.62 by $0.05. Agilent Technologies had a net margin of 15.30% and a return on equity of 16.96%. The firm had revenue of $1.19 billion for the quarter, compared to analysts’ expectations of $1.17 billion. During the same period in the previous year, the firm posted $0.59 EPS. The company’s revenue for the quarter was up 7.0% on a year-over-year basis. sell-side analysts anticipate that Agilent Technologies, Inc. will post 2.58 earnings per share for the current fiscal year.

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 24th. Stockholders of record on Tuesday, January 2nd will be paid a dividend of $0.149 per share. The ex-dividend date is Friday, December 29th. This is a positive change from Agilent Technologies’s previous quarterly dividend of $0.13. This represents a $0.60 annualized dividend and a dividend yield of 0.89%. Agilent Technologies’s payout ratio is currently 25.24%.

ILLEGAL ACTIVITY NOTICE: This report was originally posted by Week Herald and is the sole property of of Week Herald. If you are accessing this report on another domain, it was illegally copied and reposted in violation of US & international copyright & trademark law. The correct version of this report can be accessed at https://weekherald.com/2017/12/14/americafirst-capital-management-llc-purchases-new-stake-in-agilent-technologies-inc-a.html.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business.

Institutional Ownership by Quarter for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply